S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
S&P 500   5,088.52 (+-0.01%)
DOW   39,174.31 (+0.11%)
QQQ   437.88 (+0.25%)
AAPL   181.71 (-0.44%)
MSFT   409.64 (-0.17%)
META   483.14 (-0.18%)
GOOGL   140.09 (-2.69%)
AMZN   175.78 (+0.45%)
TSLA   197.49 (+2.88%)
NVDA   797.31 (+1.16%)
NIO   5.69 (+5.37%)
AMD   176.35 (-0.10%)
BABA   76.47 (+0.67%)
T   16.62 (-1.07%)
F   12.17 (+0.25%)
MU   90.17 (+4.85%)
CGC   3.48 (+3.57%)
GE   154.69 (+0.89%)
DIS   108.44 (+0.65%)
AMC   4.55 (+2.48%)
PFE   27.24 (-1.87%)
PYPL   59.79 (+1.06%)
XOM   104.68 (+0.81%)
OTCMKTS:AXIM

AXIM Biotechnologies (AXIM) Stock Price, News & Analysis

$0.02
0.00 (-9.34%)
(As of 02/23/2024 08:54 PM ET)
Today's Range
$0.0150
$0.0179
50-Day Range
$0.01
$0.02
52-Week Range
$0.01
$0.06
Volume
1.01 million shs
Average Volume
303,951 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AXIM stock logo

About AXIM Biotechnologies Stock (OTCMKTS:AXIM)

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

AXIM Stock Price History

AXIM Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Axim Fishermen Hail Govt
MASLOC Trial: Daniel Axim Denies Charges
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
LLBO Lifeline Biotechnologies, Inc.
Axim Fishermen Plead For More Premix
AXIM - AXIM Biotechnologies, Inc.
See More Headlines
Receive AXIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/26/2024
Next Earnings (Estimated)
4/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:AXIM
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. John W. Huemoeller II (Age 69)
    President, CEO & Director
    Comp: $420k
  • Mr. Robert T. Malasek (Age 56)
    CFO & Secretary
    Comp: $90k
  • Ms. Catalina Valencia J.D. (Age 75)
    Co-Founder & CEO of Sapphire Biotech, Inc.
    Comp: $187.5k
  • Mr. Kurt Phinney (Age 52)
    Chief Operating Officer
  • Dr. Sergei A. Svarovsky M.B.A.
    Ph.D., Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc.
  • Dr. Alim Seit-Nebi Ph.D.
    CTO & Co-Founder of Sapphire Biotech, Inc.
  • Mr. Jeffrey A. Busby
    Senior Vice President of Business Development
  • Dr. Joseph Tauber M.D. (Age 67)
    Chief Medical Officer & Chairman of the Medical Advisory Board














AXIM Stock Analysis - Frequently Asked Questions

How have AXIM shares performed in 2024?

AXIM Biotechnologies' stock was trading at $0.0190 at the beginning of the year. Since then, AXIM stock has decreased by 13.2% and is now trading at $0.0165.
View the best growth stocks for 2024 here
.

When is AXIM Biotechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 17th 2024.
View our AXIM earnings forecast
.

What other stocks do shareholders of AXIM Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include Cronos Group (CRON), Tilray (TLRY), KushCo (KSHB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Fulcrum Therapeutics (FULC) and Alibaba Group (BABA).

How do I buy shares of AXIM Biotechnologies?

Shares of AXIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AXIM) was last updated on 2/26/2024 by MarketBeat.com Staff